NQF endorses pulmonary and infectious disease measures

Luke Gale | | Health Exec | Economics

The National Quality Forum (NQF) has endorsed 14 infectious disease quality measures and an additional pulmonary quality measure.

The endorsements were made as NQF engages in an quality measure maintenance program to ensure that they are current, best-in-class and synchronistic with with national priorities, according to a Jan. 8 statement.

Visit the NQF website to view more details on the pulmonary and infectious disease quality measures. 

Luke Gale

Related Content

Cardiologist demand is on the rise—can hospitals keep up?
Cardinal Health scoops up two companies for $3.9B
UnitedHealth defends $3.3B Amedisys acquisition
DOJ sues to block UnitedHealth’s $3.3B acquisition of home health giant
Private equity firm to buy Summa Health for $485M
Private equity transactions in healthcare down 15% since 2023, report finds

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup